Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3, with HHS Vulnerability Disclosure and Revision: v3.3.2 removed.
    Difference
    0.1%
    Check dated 2025-12-23T12:37:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision history shows a new entry v3.3.2 and removal of v3.2.0. No substantive study content or eligibility details were changed.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:08.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. No core study information such as eligibility criteria, interventions, or contact details appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T17:44:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The new screenshot shows minor visual/layout adjustments to the study page, while core study details (conditions, eligibility criteria, and contact information) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:32:51.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    8%
    Check dated 2025-10-05T17:19:37.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Update: version bumped to v3.1.0 with a new contact phone number 844-663-3742; previous version v3.0.2 removed.
    Difference
    0.2%
    Check dated 2025-09-28T10:11:15.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.